Market revenue in 2023 | USD 389.4 million |
Market revenue in 2030 | USD 486.1 million |
Growth rate | 3.2% (CAGR from 2023 to 2030) |
Largest segment | Nuclear medicine |
Fastest growing segment | CT |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | CT, MRI, Ultrasound, Nuclear Medicine |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, GE HealthCare Technologies Inc Common Stock, Koninklijke Philips NV, Hitachi Ltd, Samsung Electronics Co Ltd, Shimadzu Corp, Hologic Inc, Carestream Health - HCIS business |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vascular imaging market will help companies and investors design strategic landscapes.
Nuclear medicine was the largest segment with a revenue share of 32.1% in 2023. Horizon Databook has segmented the Middle East & Africa vascular imaging market based on ct, mri, ultrasound, nuclear medicine covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa vascular imaging market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa vascular imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account